Despite recent exponential growth in research on familial hypercholesterolaemia, there remains a general lack of public and health professional awareness about the disorder.

Screening and management in general practice has the potential for substantial health benefits while requiring relatively modest investments from the health system.

In April 2020, a group of general practice leaders in NSW established a COVID-19 virtual community of practice to facilitate rapid transfer and implementation of clinical guidance into practice.

The recent increased public experience with epidemiological concepts such as contact tracing offers new potential to improve detection and management of familial hypercholesterolaemia.

This study highlights the triumphs and gaps in asthma management during the COVID-19 pandemic and the vulnerability of existing asthma care systems to disruption.

Patient health literacy is a barrier to both management of familial hypercholesterolaemia and cascade testing.

Recent consensus advice on the care of patients with familial hypercholesterolaemia (FH) supports improved care of patients with FH in the primary care setting.